CBS 2019
CBSMD教育中心
中 文

Pulmonary Hypertension

Abstract

Recommended Article

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions. Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients A Case of Pulmonary Hypertension Associated with Idiopathic Hypereosinophilic Syndrome Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and D6PK Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association The right ventricle in pulmonary hypertension

Original Researche13197, 2019 Dec 27 [Online ahead of print]

JOURNAL:Eur J Clin Invest. Article Link

Improvement of Clinical Outcome in Patients With ST-Elevation Myocardial Infarction Between 1999 And 2016 in China : The Prospective, Multicenter Registry MOODY Study

MX Chen, J Kan, JJ Zhang et al. Keywords: STEMI; clinical events; in-hospital death; PCI; trained operator

ABSTRACT


BACKGROUND - Reports showed no change of 7day mortality after primary percutaneous coronary intervention (PCI) for STelevation myocardial infarction (STEMI) between 2001 and 2011 in China. National rolling oneyear interventional standardized training program began in September 2009. However, the improvement in clinical outcome following STEMI PCI after 2011 remains unclear.


METHODS AND RESULTS - This multicenter MOODY registry study aimed to analyze the clinical improvement after STEMI PCI. Of a total of 9265 acute MI patients registered from 24 centers, 3142 STEMIs having a first medical contact time 12 hours and undergoing primary PCI were assigned to the Pre Group (n=1014, between March 1999 and October 2010) or the Post Group (n=2128, between 2010 November and 2016 Ocotber). The primary endpoint was inhospital cardiac death. Study endpoints were also compared between trained and untrained operators and between experienced (50 primary PCIs/year) and inexperienced personnel.

Inhospital death after PCI was 3.0% in the Pre Group, significantly higher than 1.6% in the Post Group (p=0.035). The improvements in clinical outcome after PCI between the 2016 and Pre Groups were stably sustained through oneyear followup. The significant reduction for inhospital death was noted when primary PCI was performed by trained (1.4% vs 5.4%, p<0.001) or experienced (2.7% vs 4.8%, p=0.001) operators, compared to untrained or inexperienced operators, respectively. Inclusion of the untrained operator into the conventional risk model strongly enhanced the prediction for endpoints. Age, Killip Class 3, diabetes, transradial approach, and system delay were five predictors of inhospital death after primary PCI.


CONCLUSION - PCI for STEMI by a trained and experienced operator was associated with significant reduction of inhospital death. Our results strongly warrant the need for promoting the current system response and patient education.